Identification of a gene coding for a new squamous cell carcinoma antigen recognized by the CTL

Journal of Immunology

Volumn 164, Issue 5, 2000, Pages 2565-2574

  Nakao, Masanobu ^a,b   Shichijo, Shigeki ^a   Imaizumi, Toshihiro ^b   Inoue, Yoshiko ^b   Matsunaga, Kazuko ^b   Yamada, Akira ^b   Kikuchi, Megumi ^b   Tsuda, Naotake ^b   Ohta, Keisuke ^a   Takamori, Shinzo ^a   Yamana, Hideaki ^a   Fujita, Hiromasa ^a   Itoh, Kyogo ^a,b  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KURUME UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; HLA ANTIGEN; MESSENGER RNA;

ANTIGEN RECOGNITION; ARTICLE; CANCER IMMUNOLOGY; CANCER IMMUNOTHERAPY; CHROMOSOME 6P; CYTOTOXIC T LYMPHOCYTE; GENE SEQUENCE; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; SQUAMOUS CELL CARCINOMA; TUMOR REGRESSION;

EID: 0034161716     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.5.2565     Document Type: Article

References (46)

1. Traversari, C., P. van der Bruggen, I. F. Luescher, C. Lurquin, P. Chomez, A. Van Pel, E. De Plaen, A. Amar-Costesec, and T. Boon. 1992. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J. Exp. Med. 176:1453.
2. Van der Bruggen, P., J. Bastin, T. Gajewski, P. G. Coulie, P. Boël, C. De Smet, C. Traversari, A. Townsend, and T. Boon. 1994. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur. J. Immunol. 24:3038.
3. Kawakami, Y., S. Eliyahu, K. Sakaguchi, P. F. Robbins, L. Rivoltini, J. R. Yannelli, E. Appella, and S. A. Rosenberg. 1994. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J. Exp. Med. 180:347.
4. Kawakami, Y., S. Eliyahu, C. Jennings, K. Sakaguchi, X. Kang, S. Southwood, P. F. Robbins, A. Sette, E. Appella, and S. A. Rosenberg. 1995. Recognition of multiple epitopes in the human melanoma antigen gp 100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. J. Immunol. 154:3961.
5. Kang, X., Y. Kawakami, M. El-Gamil, R. Wang, K. Sakaguchi, J. R. Yannelli, E. Appella, S. A. Rosenberg, and P. F. Robbins. 1995. Identification of a tyrosinase epitope recognized by HLA-A24-restricted, tumor-infiltrating lymphocytes. J. Immunol. 155:1343.
6. Robbins, P. F., M. El-Gamil, Y. F. Li, Y. Kawakami, D. Loftus, E. Appella, and S. A. Rosenberg. 1996. A mutated β-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes. J. Exp. Med. 183:1185.
7. Robbins, P. F., M. El-Gamil, Y. F. Li, E. B. Fitzgerald, Y. Kawakami, and S. A. Rosenberg. 1997. The intronic region of an incompletely spliced gp100 gene transcript encodes an epitope recognized by melanoma-reactive tumor-infiltrating lymphocytes. J. Immunol. 159:303.
8. Robbins, P. F., M. El-Gamil, Y. F. Li, S. L. Topalian, L. Rivoltini, K. Sakaguchi, E. Appella, and S. A. Rosenberg. 1995. Cloning of a new gene encoding an antigen recognized by melanoma-specific HLA-A24-restricted tumor-infiltrating lymphocytes. J. Immunol. 154:5944.
9. Marchand, M., P. Weynants, E. Rankin, F. Arienti, F. Belli, G. Parmiani, N. Cascinelli, A. Bourlond, R. Vanwijck, Y. Humblet, et al. 1995. Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int. J. Cancer 63:883.
10. Rosenberg, S. A., J. C. Yang, D. J. Schwartzentruber, P. Hwu, F. M. Marincola, S. L. Topalian, N. P. Restifo, M. E. Dudley, S. L. Schwarz, P. J. Spiess, et al. 1998. Immunologic and therapeutic evaluation of synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat. Med. 4:321.
11. Nestle, F. O., S. Alijagic, M. Gilliet, Y. Sun, S. Grabbe, R. Dummer, G. Burg, and D. Schadendorf. 1998. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat. Med. 4:328.
12. Mandruzzato, A., F. Brasseur, G. Andry, T. Boon, and P. van der Bruggen. 1997. A CASP-8 mutation recognized by cytotoxic T lymphocytes on a human head and neck carcinoma. J. Exp. Med. 186:785.
13. Jäger, E., Y. T. Chen, J. W. Drijfhout, J. Karbach, M. Ringhoffer, D. Jäger, M. Arand, H. Wada, Y. Noguchi, E. Stocken, et al. 1998. Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitope. J. Exp. Med 187:265.
14. Shichijo, S., M. Nakao, Y. Imai, H. Takasu, M. Kawamoto, F. Niiya, D. Yang, Y. Ton, H. Yamana, and K. Itoh. 1998. A gene encoding antigenic peptides of human squamous cell carcinoma recognized by cytotoxic T lymphocytes. J. Exp. Med. 187:277.
15. Yang, D., M. Nakao, S. Shichijo, T. Sasatomi, H. Takasu, H. Matsumoto, K. Mori, A. Hayashi, H. Yamana, K. Shirouzu, and K. Itoh. 1999. Identification of a gene coding for a protein shared tumor epitopes capable of inducing HLA-A24-restricted cytotoxic T lymphocytes in cancer patients. Cancer Res. 59:4056.
16. Kikuchi, M., M. Nakao, Y. Inoue, K. Matsunaga, S. Shichijo, H. Yamana, and K. Itoh. 1999. Identification of a SART-1-derived peptide capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes. Int. J. Cancer 81:451.
17. Nakao, M., H. Yamana, Y. Imai, Y. Toh, U. Toh, A. Kimura, S. Yanoma, T. Kakegawa, and K. Itoh. 1995. HLA A2601-restricted CTLs recognize a peptide antigen expressed on squamous cell carcinoma. Cancer Res. 55:4248.
18. Hoshino, T., N. Seki, M. Kikuchi, T. Kuramoto, O. Iwamoto, I. Kodama, K. Koufuji, J. Takeda, and K Itoh. 1997. HLA-class-I-restricted and tumor-specific CTL in tumor-infiltraing lymphocytes of patients with gastric cancer. Int. J. Cancer 70:631.
19. Miyajima, J., Y. Imai, M. Nakao, S. Noda, and K. Itoh. 1997. Higher susceptibility of erythropoietin-producing renal cell carcinoma to lysis by lymphokine-activated killer cells. J. Immunother. 19:399.
20. Uhi, T., H. Yamana, M. Nakao, Y. Imai, N. Seki, H. Takasu, T. Kaneshige, H. Fujita, K. Shirouzu, and K. Itoh. 1997. HLA-class I-restricted and tumor-specific cytotoxic T lymphocytes from metastatic lymph nodes of esophageal cancers. Cell. Immunol. 177:137.
21. Matsumoto, H., S. Shichijo, K. Kawano, T. Nishida, M. Sakamoto, and K. Itoh, 1999. Expression of the SART-1 antigen in uterus cancers. Jpn. J. Cancer Res. 89:1292.
22. Yamada, A., K. Kawano, N. Harashima, F. Niiya, K. Nagai, T. Kohayashi, T. Mine, K. Ushijima, T. Nishida, and K. Itoh. 1999. Study of HLA class I restriction and the directed antigens of cytotoxic T lymphocytes at the tumor sites of ovarian cancer. Cancer Immunol. Immunother. 48:147.
23. Kawamoto, M., S. Shichijo, Y. Imai, T. Imaizumi, T. Koga, H. Yanaga, and K. Itoh. 1999. Expression of the SART-1 tumor rejection antigen in breast cancer. Int. J. Cancer 80:64.
24. Imaizumi, T., T. Kuramoto, K. Matsunaga, S. Shichijo, S. Yutani, M. Shigemori, K. Oizumi, and K. Itoh. 1999. Expression of the tumor-rejection antigen SART1 in brain tumors. Int. J. Cancer. 83:760.
25. Yamada, A., M. Stereuli, H. Saito, D. M. Rothstein, S. F. Schlossman, and C. Morimoto. 1990. Effect of activation of protein kinase C on CD45 isoform expression and CD45 protein tyrosine phophatase activity in T cells. Eur. J. Immunol. 20:1655.
26. Balch, W. E., W. G. Durphy, W. A. Braell, and J. Rothman. 1984. Reconstitution of the transport of protein between successive compartments of the Golgi measured by the coupled incorporation of N-acetylglucosamine. Cell 39:405.
27. Murakami, K., K. Mihara, and T. Omura. 1994. The transmembrane region of mucosal cytochrome P450 identified as the endoplasmic reticulum retention signal. J. Biochem. 116:164.
28. Kubo, R. T., A. Sette, H. M. Grey, E. Appella, K. Sakaguchi, N.-Z. Zhu, D. Arnott, N. Sherman, J. Shabanowitz, H. Michel, et al. 1994. Definition of specific peptide motifs for four major HLA-A alleles. J. Immunol. 152:3913.
29. Ton, N., M. Schumacher, M.-T. Heemels, J. J. Neefjes, W. M. Kast, C. J. M. Melief, and H. L. Ploegh. 1990. Direction binding of peptide to empty MHC class I molecules on intact cells and in vitro. Cell 62:563.
30. Rammensee, H.-G., T. Friede, and S. Stevanovic. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics 41:178.
31. Taswell, C. 1981. Limiting dilution assays for the determination of immunocompetent cell frequency. J. Immunol. 126:1614.
32. Stephen, A. F., T. L. Madden, A. A. Schäffer, J. Zhang, Z. Zhang, W. Miller, and D. J. Lipman. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:3389.
33. Bram, R. J., D. T. Hung, P. K. Martin, S. T. Schreiber, and G. R. Crabtree. 1993. Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: roles of calcineurin binding and cellular location. Mol. Cell. Biol. 13:4760.
34. Arber, S., K.-H. Krause, and P. Caroli. 1992. S-cyclophilin is retained intracellularly via a unique COOH-terminal sequence and colocalizes with the calcium storage protein calreticulin. J. Cell Biol. 116:113.
35. Stryer, L. 1988. Protein targeting. In Biochemistry, 3rd Ed. L. Stryer, ed. W. H. Freeman and Company, New York, p. 767.
36. Teasdale, R. D., and M. R. Jackson. 1996. Signal-mediated sorting of membrane proteins between the endoplasmic reticulum and the Golgi apparatus. Annu. Rev. Cell. Dev. Biol. 12:27.
37. Gomi, S., M. Nakao, F. Niiya, Y. Imamura, K. Kawano, S. Nishizaka, A. Hayashi, Y. Sobao, K. Oizumi, and K. Itoh. 1999. A cyclophilin B gene encodes antigenic epitopes recognized by HLA-A24-restricted and tumor-specific CTLs. J. Immunol. In press.
38. Bram, R. J., and G. R. Crabtree. 1994. Calcium signaling in T cells stimulated by a cyclophilin B-binding protein. Nature 371:355.
39. Correale, P., K. Walmsley, C. Nieroda, S. Zaremda, M. Zhu, J. Schlom, and K. Y. Tsung. 1997. In virtro generation of human cytotoxic T lymphocytes specific antigen. J. Natl. Cancer Inst. 89:293.
40. Correale, P., K. Walmsley, S. Zaremba, M. Zhu, J. Schlom, and K. Y. Tsung. 1998. Generation of human cytolytic T lymphocyte lines directed against prostate-specific antigen (PSA) employing a PSA oligoepitope peptide. J. Immunol. 161:3186.
41. Peoples, G. E., P. S. Goedegebuure, R. Smith, D. C. Linehan, I. Yoshino, and T. J. Eberlein. 1995. Breast and ovarian cancer-specific cytotoxic T lymphocytes recognized the same HER-2/neu-derived peptide. Proc. Natl. Acad. Sci. USA 92:432.
42. Fisk, B., T. L. Blevins, J. Wharton, and C. Iodinnedes. 1995. Identification of an immunodominant peptide of HER-2/neu proto-oncogene recognized by ovarian tumor-specific cytotoxic T lymphocytes lines. J. Exp. Med. 181:1185.
43. INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 269:1281.
44. Kawakami, Y., and S. A. Rosenberg. 1996. T-cell recognition of self peptide as tumor rejection antigens. Immunol. Res. 15:179.
45. Tokunaga, K., Y. Ishikawa, A. Ogawa, H. Wang, S. Matsunaga, S. Moriyama, L. Lin, M. Bannai, Y. Watanabe, K. Kashiwase, et al. 1997. Sequence-based association analysis of HLA class I and II alleles in Japanese supports conservation of common haplotypes. Immunogenetics 46:199.
46. Imanishi, T., T. Akaza, A. Kimura, K. Tokunaga, and T. Gojobori. 1992. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In HLA 1991, Vol. 1. K. Tsuji, M. Aizawa, and T. Sasazuki, eds. Scientific Publications, Oxford, p. 1065.